XORTX Therapeutics Inc. - Common Shares, no par value per share (XRTX)

Historical Holders from Q4 2023 to Q3 2025

Symbol
XRTX on Nasdaq
CUSIP
98420Q306
Type / Class
Equity / Common Shares, no par value per share
Shares outstanding
5.78M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
101K
Holdings value
$81.5K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
5
Number of buys
3
Number of sells
-4
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of XORTX Therapeutics Inc. - Common Shares, no par value per share (XRTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lincoln Alternative Strategies LLC 9.9% $498K 572K Lincoln Alternative Strategies LLC Oct 23, 2025
ARMISTICE CAPITAL, LLC 4.99% -50% $151K -$143K 178K -48.7% Armistice Capital, LLC Mar 31, 2025

Institutional Holders of XORTX Therapeutics Inc. - Common Shares, no par value per share (XRTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 101K $81.5K +$27.9K $0.81 5
2025 Q2 64.6K $60.2K +$59.8K $0.92 6
2025 Q1 451 $416 -$324K $0.91 2
2024 Q4 287K $325K +$296K $1.13 6
2024 Q3 24.7K $41.1K +$12.4K $1.64 7
2024 Q2 15.2K $29.2K -$34.5K $1.90 5
2024 Q1 16.4K $65.3K -$161M $3.99 3
2023 Q4 2.76M $161M +$161M $58.15 1